Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

130 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

NCT02918695

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: ZNA Antwerpen Antwerp, Belgium

Centre Hospitalier EpiCURA Baudour, Belgium

Imelda Ziekenhuis Bonheiden, Belgium

AZ Klina Brasschaat, Belgium

View all 20 locations

View Trial Details

Completed

SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain

NCT03006718

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Completed

Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease

NCT00071032

Conditions: Anemia, Brain Diseases, Cardiovascular Diseases, +23 more
Locations: University Medicine & Dentistry of NJ New Brunswick, New Jersey, United States

View Trial Details

Completed

Evaluation, Treatment, and Training for Patients With Blood Disorders

NCT00001397

Conditions: Agranulocytosis, Anemia, Blood Platelet Disorders, +10 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

NCT00006400

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Howard University Washington D.C., District of Columbia, United States

University of Miami Miami, Florida, United States

View all 14 locations

View Trial Details

Completed

Prospective Study of Patients With Thrombocytopenia Following HSCT

NCT02487563

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +2 more
Locations: The First affiliated Hospital of SooChow University Suzhou, Jiangsu, China

View Trial Details

Completed

Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach

NCT03540654

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: CHU Bordeaux Bordeaux, France

View Trial Details

Completed

A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF

NCT01787552

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations: Novartis Investigative Site Camperdown, New South Wales, Australia

Novartis Investigative Site Woolloongabba, Queensland, Australia

Novartis Investigative Site Leuven, Belgium

Novartis Investigative Site Toronto, Ontario, Canada

View all 18 locations

View Trial Details

Completed

Ultra Low Dose Interleukin-2 in Healthy Volunteers

NCT01445561

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

NCT00213239

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Neoplasms
Locations: The Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details